Skip to main content
HR 853 117th Congress House Health Drug therapy Health care costs and insurance Inflation and prices Prescription drugs

Closing Loopholes for Orphan Drugs Act

Introduced: February 4, 2021 Introduced by: Welch, Peter Democratic · Vermont See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2021
Referred to the Subcommittee on Health.
Feb 4, 2021
Referred to the House Committee on Energy and Commerce.
Feb 4, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Closing Loopholes for Orphan Drugs Act

This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.

What's happening now February 5, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2